483
Continental Services Group, Inc.FDA 483 - Continental Services Group, Inc. - April 30, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Continental Services Group, Inc., a blood bank in Ft Lauderdale, FL, revealed two significant observations. The firm failed to adequately investigate and follow up on severe donor reactions, and also failed to properly store and segregate expired supplies, creating a risk of inadvertent use in blood collection and processing operations.
Open in Dashboard
ID · 30114164-3de6-4925-affb-edfabea9cc49